MSKCC Researchers Detail Data Management, Analysis Pipelines for NGS-based Clinical Dx Assays | GenomeWeb

Researchers in the pathology and bioinformatics arms of the Memorial Sloan-Kettering Cancer Center are developing pipelines that will be eventually be used to manage and analyze data and workflows for the center's next-generation sequencing-based clinical diagnostic assays.

Both pipelines combine open source software and internally developed applications into a scalable automated infrastructure for managing and analyzing data that is currently being used in cancer research studies at MSKCC, including one focused on detecting low-frequency somatic mutations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.